A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
17-Hydroxyprogesterone
Test CodeAlias/See Also
LAB720
CPT Codes
<p>83498</p>
Preferred Specimen
Specimen Type: Serum Red
Collection Container/Type: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
- Separate serum after clotting.
- Ship serum refrigerated or frozen.
Specimen Type: Plasma
Collection Container/Type
Preferred: Lavender top (EDTA)
Acceptable: Royal blue-top (EDTA) plastic trace element blood collection tube, Green top (Sodium heparin), Green top (Lithium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Minimum Volume
0.25 mL
Other Acceptable Specimens
Instructions
Transport Temperature
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 2 years
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Serum separator tube
Methodology
Chromatography/Mass Spectrometry
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Report Available
2-5 days
Reference Range
18-30 years | 32-307 ng/dL |
31-40 years | 42-196 ng/dL |
41-50 years | 33-195 ng/dL |
51-60 years | 37-129 ng/dL |
Adult Females
Pre-Menopausal Mid Follicular | 23-102 ng/dL |
Pre-Menopausal Surge | 67-349 ng/dL |
Pre-Menopausal Mid Luteal | 139-431 ng/dL |
Postmenopausal Phase | ≤45 ng/dL |
First Trimester | 78-457 ng/dL |
Second Trimester | 90-357 ng/dL |
Third Trimester | 144-578 ng/dL |
Pediatric
Cord Blood** | 1000-3000 ng/dL |
Premature Infants** (31-35 weeks) | ≤405 ng/dL |
Term Infants (12 hrs)** | <460 ng/dL |
Values decline gradually to prepubertal levels | |
Male and Female | |
<30 days | Not established |
1-11 months | ≤147 ng/dL |
1 year | ≤139 ng/dL |
2 years | ≤134 ng/dL |
3 years | ≤131 ng/dL |
4 years | ≤131 ng/dL |
5 years | ≤133 ng/dL |
6 years | ≤137 ng/dL |
7 years | ≤145 ng/dL |
8 years | ≤154 ng/dL |
9 years | ≤166 ng/dL |
10 years | ≤180 ng/dL |
11 years | ≤196 ng/dL |
12 years | ≤213 ng/dL |
13 years | ≤233 ng/dL |
14 years | ≤254 ng/dL |
15 years | 19-276 ng/dL |
16 years | 23-300 ng/dL |
17 years | 26-325 ng/dL |
Tanner Stages**
II-III Males | 12-130 ng/dL |
II-III Females | 18-220 ng/dL |
IV-V Males | 51-190 ng/dL |
IV-V Females | 36-200 ng/dL |
**Includes data from J Clin Endocrinol Metab.1991;73:674-686; J Clin Endocrinol Metab. 1989; 69:1133-1136; and J Clin Endocrinol Metab. 1994; 78:266-270. Pediatr Res 1988;23:525-529. MedLinePlus (accessed 6/16/14).
Clinical Significance
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153
Last Updated: February 16, 2012